Literature DB >> 10678308

Visual hallucinations in patients from an ophthalmology clinic and medical clinic population.

S Holroyd1, P V Rabins, D Finkelstein, M Lavrisha.   

Abstract

Although visual hallucinations have been associated with patients with visual disorders, no study has specifically examined whether visual hallucinations are indeed more prevalent than in a general medical population. In this study, 127 consecutive visual disorder patients and 100 consecutive general medical patients were screened for complex visual hallucinations. A total of 6.3% of visual disorder patients and 2% of general medical patients had visual hallucinations. Interestingly, the two medical patients with visual hallucinations also had visual disorders. Factors significantly associated with visual hallucinations were female sex (p = .029) and lower cognitive score (p = .001). Data from a previous study of patients with the visual disorder age-related macular degeneration were combined with this study to increase the sample size of visual hallucinators. Factors significantly associated with visual hallucinations in the combined sample were female sex (p = .015), living alone (p = .019), having hearing problems (p = .047), older age (p = .013), and lower cognitive score (p < .001). Implications and future research are discussed.

Entities:  

Mesh:

Year:  1994        PMID: 10678308     DOI: 10.1097/00005053-199405000-00004

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  9 in total

1.  Charles Bonnet syndrome in patients with glaucoma and good acuity.

Authors:  S A Madill; D H Ffytche
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

2.  Contrast sensitivity and visual hallucinations in patients referred to a low vision rehabilitation clinic.

Authors:  M L Jackson; K Bassett; P V Nirmalan; E C Sayre
Journal:  Br J Ophthalmol       Date:  2006-10-11       Impact factor: 4.638

3.  Prospective study of hallucinations and delusions in Parkinson's disease.

Authors:  S Holroyd; L Currie; G F Wooten
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

4.  Acute Reversible Charles Bonnet Syndrome Following Eye Patch Placement.

Authors:  Lian Nan; Hou Yanbin; Zhao Jingping
Journal:  Neuroophthalmology       Date:  2013-01-29

Review 5.  Visual Impairment and Mental Health: Unmet Needs and Treatment Options.

Authors:  Docia L Demmin; Steven M Silverstein
Journal:  Clin Ophthalmol       Date:  2020-12-03

6.  Charles Bonnet's syndrome: not only a condition of the elderly.

Authors:  Heike M Elflein; M Rudy; K Lorenz; K A Ponto; A Scheurich; S Pitz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-25       Impact factor: 3.117

7.  Charles Bonnet syndrome in Asian patients in a tertiary ophthalmic centre.

Authors:  C S H Tan; V S Y Lim; D Y M Ho; E Yeo; B Y Ng; K G Au Eong
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

8.  Negative outcome Charles Bonnet syndrome.

Authors:  Thomas M Cox; Dominic H ffytche
Journal:  Br J Ophthalmol       Date:  2014-05-13       Impact factor: 4.638

9.  Exacerbation of visual hallucinations in Charles Bonnet syndrome due to the social implications of COVID-19.

Authors:  Lee Jones; Lara Ditzel-Finn; Judith Potts; Mariya Moosajee
Journal:  BMJ Open Ophthalmol       Date:  2021-02-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.